Lechner et al. [54] observed Tregs (identified as CD4+/FoxP3+ CD127low) in blood (PBMC’s) to be elevated in the SCCHN group compared to healthy donors. The gene discussed is CD4; the disease is head and neck squamous cell carcinoma.